RxDoctor Payments Data

Jeffrey Weber, MD

Gastroenterology · Milwaukee, WINPI 1962465047

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Amgen at 37.1% of the total. That places this record below the midpoint for gastroenterology clinicians in WI, where the typical reported total is $253.

$206in general payments, 2019–2025

Across 9 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$76
  • AbbVie$62
  • Octapharma USA, Inc.$36
  • Daiichi Sankyo Inc.$17
  • Biogen$15
$193,655in research payments, 2019–2025

Across 11 payments — averaging $17,605 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$186K
  • AstraZeneca$8K

What the payments were for

  • Food & beverage$206100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen3$76
AbbVie3$62
Octapharma USA, Inc.1$36
Daiichi Sankyo Inc.1$17
Biogen1$15

How this compares

$206 in reported general payments places this provider in the 45th percentile of 285 gastroenterology providers in Wisconsin.

See all gastroenterology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$46,448,211
Medicare patients
2,235
Services billed
2,351,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →